Its crucial to balance drug use with lifestyle changes, ensuring sustainable health benefits
Is retatrutide more effective than tirzepatide for weight loss
The Future of Oral GLP-1 Medications Innovations on the Horizon The success of Rybelsus has paved the way for further research into oral GLP-1 medications
20 :5-8 Key words: type 2 diabetes, cardiovascular outcome studies, SGLT2 inhibitors, GLP-1 receptor agonists, pioglitazone, REWIND, DAPA-HF, PIONEER 6 As we enter a new decade it is timely to reflect on the many advances in pharmacological therapies for type 2 diabetes that occurred with respect to cardiovascular protection during the last 5 years
Strategies to manage them include: Start low, increase slowly: Begin with the lowest dose recommended by your licensed healthcare provider
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications Lincoff, A